Overview
On 16 November 2004, orphan designation (EU/3/04/242) was granted by the European Commission to AB Science, France, for N-(methyl-diazacyclohexyl methylbenzamide)-azaphenyl-aminothiopyrrole for the treatment of mastocytosis.
Key facts
Active substance |
N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole
|
Intended use |
Treatment of mastocytosis
|
Orphan designation status |
Positive
|
EU designation number |
EU/3/04/242
|
Date of designation |
16/11/2004
|
Sponsor |
AB Science
3, avenue Gerorge F-75008 Paris France Telephone: + 33 1 47 20 10 35 Telefax: + 33 1 47 20 24 11 E-mail: contact@ab-science.com |
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: